BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29273521)

  • 21. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
    Logue MW; Posner H; Green RC; Moline M; Cupples LA; Lunetta KL; Zou H; Hurt SW; Farrer LA; Decarli C;
    Alzheimers Dement; 2011 Sep; 7(5):493-500. PubMed ID: 21723205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathology of "vascular dementia": a critical update.
    Jellinger KA
    J Alzheimers Dis; 2008 May; 14(1):107-23. PubMed ID: 18525132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vascular cognitive impairment: the relationship between hypertensive small vessel disease and cerebral amyloid angiopathy].
    Tomimoto H
    Brain Nerve; 2012 Dec; 64(12):1377-86. PubMed ID: 23209064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular disease and dementia.
    Knopman DS
    Br J Radiol; 2007 Dec; 80 Spec No 2():S121-7. PubMed ID: 18445742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features and Experimental Models of Cerebral Small Vessel Disease.
    Shindo A; Ishikawa H; Ii Y; Niwa A; Tomimoto H
    Front Aging Neurosci; 2020; 12():109. PubMed ID: 32431603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    McAleese KE; Miah M; Graham S; Hadfield GM; Walker L; Johnson M; Colloby SJ; Thomas AJ; DeCarli C; Koss D; Attems J
    Acta Neuropathol; 2021 Dec; 142(6):937-950. PubMed ID: 34608542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the pathology of vascular cognitive impairment.
    Jellinger KA
    J Neurol Sci; 2005 Mar; 229-230():57-63. PubMed ID: 15760620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular dementia: still a debatable entity?
    Loeb C; Meyer JS
    J Neurol Sci; 1996 Nov; 143(1-2):31-40. PubMed ID: 8981295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of static brain lesions in vascular dementia: implications for clinical trials.
    Erkinjuntti T; Bowler JV; DeCarli CS; Fazekas F; Inzitari D; O'Brien JT; Pantoni L; Rockwood K; Scheltens P; Wahlund LO; Desmond DW
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S81-90. PubMed ID: 10609686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia.
    Zhang H; Yang Y; Zhang J; Huang L; Niu Y; Chen H; Liu Q; Wang R
    Neuroscience; 2024 Feb; 538():1-10. PubMed ID: 37913862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
    Helman AM; Murphy MP
    Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of vascular pathology to the clinical expression of dementia.
    Strozyk D; Dickson DW; Lipton RB; Katz M; Derby CA; Lee S; Wang C; Verghese J
    Neurobiol Aging; 2010 Oct; 31(10):1710-20. PubMed ID: 18996621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
    Dickie DA; Quinn TJ; Dawson J
    Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia.
    Swartz RH; Stuss DT; Gao F; Black SE
    Stroke; 2008 Mar; 39(3):822-30. PubMed ID: 18258840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review.
    Jiwa NS; Garrard P; Hainsworth AH
    J Neurochem; 2010 Nov; 115(4):814-28. PubMed ID: 20731763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia.
    Hainsworth AH; Markus HS; Schneider JA
    Hypertension; 2024 Jan; 81(1):75-86. PubMed ID: 38044814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral amyloid angiopathy as a cause of neurodegeneration.
    Smith EE
    J Neurochem; 2018 Mar; 144(5):651-658. PubMed ID: 28833176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.
    Kalaria RN; Sepulveda-Falla D
    Am J Pathol; 2021 Nov; 191(11):1888-1905. PubMed ID: 34331941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.